TGF-β signaling is required for the function of insulin-reactive T regulatory cells

We have previously isolated insulin-reactive Tregs from diabetic NOD mice designated 2H6, from which TCR transgenic mice were generated. The T cells from these 2H6 transgenic mice recognize insulin but have suppressive properties in vitro. They protect NOD mice in vivo from spontaneous development of diabetes and adoptive transfer of disease caused by polyclonal diabetogenic spleen cells as well as the highly diabetogenic monoclonal BDC2.5 TCR transgenic T cells that recognize an islet granule antigen. Using cells from both NOD and BDC2.5 mice that express a dominant-negative TGF-β receptor type II (TGF-βDNRII), we show that 2H6 T cells protected from disease by producing TGF-β and that the ability of the target diabetogenic T cells to respond to TGF-β was crucial. We further demonstrate that TGF-β signaling in 2H6 cells was important for their protective properties, as 2H6 cells were unable to protect from adoptive transfer–induced diabetes if they were unable to respond to TGF-β. Thus, our data demonstrate that insulin-specific regulatory cells protect from diabetes by virtue of their production of TGF-β1 that acts in an autocrine manner to maintain their regulatory function and acts in a paracrine manner on the target cells.

[1]  A. Pugliese The Insulin Gene In Type 1 Diabetes , 2005, IUBMB life.

[2]  P. Raskin,et al.  Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial. , 2005, Diabetes care.

[3]  G. Eisenbarth,et al.  The Stages of Type 1A Diabetes , 2005, Annals of the New York Academy of Sciences.

[4]  G. Eisenbarth,et al.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice , 2005, Nature.

[5]  D. Hafler,et al.  Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope , 2005, Nature.

[6]  J. Krischer,et al.  Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. , 2005, Diabetes care.

[7]  G. Eisenbarth,et al.  The stages of type 1A diabetes: 2005 , 2005, Immunological reviews.

[8]  S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[9]  R. Coffman,et al.  T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[10]  Bingye Han,et al.  Individual Nonobese Diabetic Mice Exhibit Unique Patterns of CD8+ T Cell Reactivity to Three Islet Antigens, Including the Newly Identified Widely Expressed Dystrophia Myotonica Kinase1 , 2004, The Journal of Immunology.

[11]  C. Benoist,et al.  Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. , 2004, Diabetes.

[12]  Jeffrey A. Bluestone,et al.  In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.

[13]  Peter R. Galle,et al.  Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 , 2004, The Journal of Immunology.

[14]  Christiane Pontoux,et al.  Immune Regulation by Self-Reactive T Cells is Antigen Specific1 , 2004, The Journal of Immunology.

[15]  Mark Peakman,et al.  Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. , 2004, The Journal of clinical investigation.

[16]  B. Brors,et al.  Medullary Epithelial Cells of the Human Thymus Express a Highly Diverse Selection of Tissue-specific Genes Colocalized in Chromosomal Clusters , 2004, The Journal of experimental medicine.

[17]  E. Schmitt,et al.  Human CD4+CD25+ regulatory T cells and infectious tolerance. , 2004, Transplantation.

[18]  M. Deeg,et al.  Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes , 2004, Diabetologia.

[19]  J. Shabanowitz,et al.  Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[21]  H. Weiner,et al.  Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. , 2003, Journal of autoimmunity.

[22]  H. Mcdevitt,et al.  CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer , 2002, The Journal of experimental medicine.

[23]  S. Strobel Oral Tolerance, Systemic Immunoregulation, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.

[24]  Yongzhong Wei,et al.  Role of TGFβ in Development of Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice1 , 2001, The Journal of Immunology.

[25]  M. Roncarolo,et al.  Type 1 T regulatory cells , 2001, Immunological reviews.

[26]  A. Gaur,et al.  A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. , 2001, The Journal of clinical investigation.

[27]  Clemencia Pinilla,et al.  Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice1 , 2001, The Journal of Immunology.

[28]  V. Kuchroo,et al.  Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Mahavir Singh,et al.  A Conserved Mycobacterial Heat Shock Protein (hsp) 70 Sequence Prevents Adjuvant Arthritis upon Nasal Administration and Induces IL-10-Producing T Cells That Cross-React with the Mammalian Self-hsp70 Homologue1 , 2000, The Journal of Immunology.

[30]  R. Flavell,et al.  Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease , 2000 .

[31]  F. Lepault,et al.  Characterization of Peripheral Regulatory CD4+ T Cells That Prevent Diabetes Onset in Nonobese Diabetic Mice1 , 2000, The Journal of Immunology.

[32]  R. Flavell,et al.  Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. , 2000, Immunity.

[33]  P. Bingley,et al.  Insulin autoantibodies: more specific than proinsulin autoantibodies for prediction of type 1 diabetes. , 1999, Journal of autoimmunity.

[34]  D. Wraith,et al.  Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. , 1999, International immunology.

[35]  C. Janeway,et al.  Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library , 1999, Nature Medicine.

[36]  H. Weiner,et al.  Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes. , 1999, Journal of autoimmunity.

[37]  S. Wahl,et al.  Engagement of Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Induces Transforming Growth Factor β (TGF-β) Production by Murine CD4+ T Cells , 1998, The Journal of experimental medicine.

[38]  C. Piccirillo,et al.  TGF-β1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice , 1998, The Journal of Immunology.

[39]  J. Miyazaki,et al.  Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1. , 1998, The Journal of clinical investigation.

[40]  C. Piccirillo,et al.  TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. , 1998, Journal of immunology.

[41]  P. Santamaria,et al.  A Mechanism for the Major Histocompatibility Complex–linked Resistance to Autoimmunity , 1997, The Journal of experimental medicine.

[42]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[43]  D. Cohen,et al.  Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. , 1997, The Journal of clinical investigation.

[44]  H. Weiner,et al.  Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. , 1997, Journal of autoimmunity.

[45]  L. Wen,et al.  Inhibition of Diabetes by an Insulin-Reactive CD4 T-Cell Clone in the Nonobese Diabetic Mouse , 1997, Diabetes.

[46]  M. Kurrer,et al.  Beta cell apoptosis in T cell-mediated autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Wegmann,et al.  Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  V. Kouskoff,et al.  Cassette vectors directing expression of T cell receptor genes in transgenic mice. , 1995, Journal of immunological methods.

[49]  R. Gill,et al.  Analysis of the spontaneous T cell response to insulin in NOD mice. , 1994, Journal of autoimmunity.

[50]  H. Weiner,et al.  Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. , 1994, Science.

[51]  Susumu Tonegawa,et al.  High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice , 1994, Cell.

[52]  D. Wegmann,et al.  Insulin‐specific T cells are a predominant component of islet infiltrates in pre‐diabetic NOD mice , 1994, European journal of immunology.

[53]  C. Benoist,et al.  Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.

[54]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[55]  G. Lathrop,et al.  Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility , 1991, Nature.

[56]  M. Atkinson,et al.  Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy , 1990, Diabetes.

[57]  K. Lafferty,et al.  T-Lymphocyte Clone Specific for Pancreatic Islet Antigen , 1988, Diabetes.